No Data
No Data
Esperion Therapeutics, Micro Labs Settle Generic Nexletol Patent Dispute
Esperion Reaches Settlement Agreement With ANDA Filer Micro Labs Not to Market Generic Version of Nexletol Prior to April 19, 2040
Express News | Esperion Therapeutics Inc - Settles Patent Litigation With Micro Labs
Express News | Esperion Reaches Settlement Agreement With Anda Filer Not to Market Generic Version of Nexletol® (Bempedoic Acid) Prior to April 19, 2040
Esperion Reaches Settlement Agreement With ANDA Filer Not to Market Generic Version of NEXLETOL (Bempedoic Acid) Prior to April 19, 2040
Trump Renews Push for Most-Favored-Nation Drug Pricing. What It All Means
Triple Nickle 1 : quit selling it if you want more